Latest / Cyrona Cell Podcast: Stem Cell Therapy in Malaysia / Stem Cell Therapy for Psoriasis: Supporting Healthier Skin and Immune Balance
Transcript
- 0:00SPEAKER_00: Welcome to the Sorona Cell Podcast.
- 0:02SPEAKER_01: Glad to be here.
- 0:02SPEAKER_00: And I want to warmly welcome you, our listener, to today's deep dive.
- 0:07SPEAKER_00: We are getting into some incredibly fascinating stuff today.
- 0:10SPEAKER_01: Oh, absolutely.
- 0:11SPEAKER_01: The source material we have is just uh it's really dense, but so rewarding.
- 0:17SPEAKER_00: It really is.
- 0:17SPEAKER_00: Today we are exploring a huge stack of materials directly from Zarona Cell.
- 0:22SPEAKER_01: Right, the Regenerative Medicine Center.
- 0:23SPEAKER_00: Exactly.
- 0:24SPEAKER_00: They're a doctor-led center based in Kuala Lumpur, Malaysia.
- 0:27SPEAKER_00: And we have access to their clinical protocols, their overarching philosophical framework, and their specific research literature.
- 0:35SPEAKER_00: Trevor Burrus, Jr.
- 0:35SPEAKER_01: And it's all focused on treating psoriasis, right?
- 0:37SPEAKER_01: Sure.
- 0:38SPEAKER_01: Which is just a notoriously stubborn condition.
- 0:40SPEAKER_01: Trevor Burrus, Jr.
- 0:41SPEAKER_00: So stubborn.
- 0:42SPEAKER_00: And our mission for this deep dive is to really cut through the intense internet hype surrounding stem cells.
- 0:47SPEAKER_01: Aaron Powell Because there's a lot of hype out there.
- 0:49SPEAKER_00: Trevor Burrus So much.
- 0:50SPEAKER_00: We want to find out what is actually happening at the cellular level for autoimmune conditions.
- 0:54SPEAKER_00: And you know, we want to understand how modern, ethically run clinics actually operate on a day-to-day basis.
- 0:59SPEAKER_01: Aaron Powell Yeah, getting past the marketing and looking at the biology.
- 1:02SPEAKER_00: Exactly.
- 1:03SPEAKER_00: Okay, let's unpack this.
- 1:04SPEAKER_01: Well, before we even look at the microscopic science, I think we need to understand the macro environment.
- 1:08SPEAKER_00: Aaron Powell You mean the clinic itself.
- 1:10SPEAKER_01: Right.
- 1:11SPEAKER_01: Who was actually delivering these therapies and uh how are they doing it safely?
- 1:17SPEAKER_01: Because Cyrena Cell isn't just a local operation.
- 1:20SPEAKER_00: No.
- 1:21SPEAKER_00: They have a massive global reach.
- 1:23SPEAKER_00: The materials mentioned, they specifically support a lot of patients flying in from Australia and the Middle East.
- 1:30SPEAKER_01: Aaron Ross Powell, which tells you something about their reputation right off the bat.
- 1:33SPEAKER_01: Aaron Powell Yeah.
- 1:33SPEAKER_00: But you know what stood out to me first?
- 1:35SPEAKER_00: The name.
- 1:37SPEAKER_01: Oh yeah.
- 1:38SPEAKER_00: Yeah.
- 1:38SPEAKER_00: It actually comes from an ancient Celtic goddess of health and protection.
- 1:41SPEAKER_01: Aaron Powell Really?
- 1:42SPEAKER_01: A Celtic goddess.
- 1:43SPEAKER_00: Yeah.
- 1:43SPEAKER_00: And I had to question this at first.
- 1:45SPEAKER_00: Like, why name a high-tech modern medical lab after an ancient Celtic goddess?
- 1:50SPEAKER_01: Aaron Powell It does seem a little uh counterintuitive for a science lab.
- 1:53SPEAKER_00: Right.
- 1:54SPEAKER_00: But then I realized it's a brilliant analogy.
- 1:56SPEAKER_00: It signals this deep focus on foundational protection, like safe, structured healing.
- 2:03SPEAKER_01: Uh as opposed to the usual marketing we see.
- 2:05SPEAKER_00: Aaron Ross Powell Exactly.
- 2:06SPEAKER_00: It's not about that miracle quick fix branding that is just everywhere in the stem cell industry right now.
- 2:12SPEAKER_01: Aaron Ross Powell That makes total sense.
- 2:13SPEAKER_01: And that protection aspect really shows up in their strict boundaries.
- 2:17SPEAKER_01: I mean they explicitly do not use embryonic stem cells.
- 2:21SPEAKER_00: Right.
- 2:21SPEAKER_00: Which is a huge ethical line.
- 2:22SPEAKER_01: Trevor Burrus Completely.
- 2:24SPEAKER_01: And they don't use experimental pluripotent stem cells either.
- 2:27SPEAKER_01: They rely entirely on ethically sourced umbilical core-drive cells.
- 2:32SPEAKER_01: Trevor Burrus, Jr.
- 2:32SPEAKER_00: The WJMSCs, right?
- 2:33SPEAKER_01: Exactly.
- 2:34SPEAKER_01: Wharton's jelly mesenchymal stem cells.
- 2:36SPEAKER_01: And they only get these from healthy full-term deliveries with complete donor consent.
- 2:41SPEAKER_00: So the ethical framework is rock solid.
- 2:43SPEAKER_01: Trevor Burrus, What's fascinating here is the rigorous safety framework they wrap around all this.
- 2:47SPEAKER_01: We're talking CGMP and ISO 9001 certified quality systems.
- 2:52SPEAKER_00: Those are serious manufacturing standards.
- 2:54SPEAKER_01: They really are.
- 2:55SPEAKER_01: And they operate with BSL2 laboratory standards.
- 2:58SPEAKER_01: So they are constantly checking identity, sterility, and viability of the cell.
- 3:01SPEAKER_00: Aaron Powell So they're not just crossing their fingers.
- 3:03SPEAKER_01: Aaron Powell Not at all.
- 3:04SPEAKER_01: It really establishes Cyrona as the adults in the room, so to speak, of regenerative medicine.
- 3:09SPEAKER_00: Aaron Powell I love that phrase, the adults in the room.
- 3:12SPEAKER_00: So we've established that Cirona focuses on very structured, serious care.
- 3:17SPEAKER_00: But why is one of their major focuses a skin condition?
- 3:21SPEAKER_01: Aaron Ross Powell Well, calling psoriasis just a skin condition kind of misses the whole picture.
- 3:25SPEAKER_00: Right.
- 3:25SPEAKER_00: Which leads us directly into the reality of psoriasis.
- 3:29SPEAKER_00: It is so much more than just a surface-level issue.
- 3:31SPEAKER_00: Trevor Burrus, Jr.
- 3:32SPEAKER_01: The sources define it as this situation where the immune system is essentially always on.
- 3:36SPEAKER_00: Like it just can't power down.
- 3:38SPEAKER_01: Exactly.
- 3:39SPEAKER_01: And that causes these thick, scaly plaques to form on the scalp, elbows, knees, the hands.
- 3:45SPEAKER_00: It sounds incredibly painful.
- 3:46SPEAKER_01: It is.
- 3:47SPEAKER_01: But it also links to profound fatigue, chronic stress, and even psoriatic arthritis.
- 3:53SPEAKER_00: So it's attacking the joints, too.
- 3:55SPEAKER_00: You know, reading through this, I kept thinking of an analogy.
- 3:57SPEAKER_00: It's like a building's fire alarm system that gets tripped, but it just refuses to turn off.
- 4:01SPEAKER_01: Well, that's a great way to picture it.
- 4:03SPEAKER_00: Right.
- 4:03SPEAKER_00: So the body's emergency responders, which in this case are the skew cells, they keep overproducing at this frantic, chaotic pace.
- 4:10SPEAKER_01: Because they think there's still a massive fire to put out.
- 4:13SPEAKER_00: Exactly.
- 4:14SPEAKER_00: And the standard care for this, you know, things like topical creams or phototherapy.
- 4:19SPEAKER_01: Or biologics.
- 4:20SPEAKER_00: Yeah, biologics.
- 4:22SPEAKER_00: The host notes that standard treatments try to block very specific pathways, things like tumor necrosis factor or TNF.
- 4:29SPEAKER_01: Or specific interleukins like IL-17 or IL-23.
- 4:33SPEAKER_00: Right.
- 4:34SPEAKER_00: But why does that sometimes fall short?
- 4:36SPEAKER_00: If we can block the pathway, shouldn't that stop the alarm?
- 4:39SPEAKER_01: Well, blocking TNF or interleukins absolutely works for many people.
- 4:43SPEAKER_01: But for others, they end up relapsing.
- 4:46SPEAKER_00: The alarm finds a way around the block.
- 4:48SPEAKER_01: Basically, yeah.
- 4:48SPEAKER_01: They stop responding to the drug or they suffer really severe side effects because you're suppressing a part of their immune system.
- 4:54SPEAKER_00: So it's like cutting the wire to one alarm bell, but the main system is still glitching out.
- 4:59SPEAKER_01: Exactly.
- 5:00SPEAKER_01: Which creates a critical need for a therapy that doesn't just block a single pathway.
- 5:04SPEAKER_01: You need something that resets the whole immune balance.
- 5:06SPEAKER_00: Okay, so if the problem is an immune system stuck in the on position, how exactly do stem cells help flip that switch?
- 5:14SPEAKER_01: This is where we get into the biological mechanism that Serana utilizes.
- 5:18SPEAKER_01: It's all about those mesenchymal stem cells we mentioned earlier.
- 5:21SPEAKER_00: The MSCs, specifically the WJ MSEs.
- 5:25SPEAKER_01: Right.
- 5:25SPEAKER_00: But wait, I need to push back on something here.
- 5:27SPEAKER_01: Sure car.
- 5:28SPEAKER_00: Because there's this massive listener misconception I think we need to clear up.
- 5:32SPEAKER_00: Aren't stem cells supposed to turn into new tissue?
- 5:35SPEAKER_00: Like, are these cells turning into new skin for the psoriasis patients?
- 5:39SPEAKER_01: Oh, I see what you mean.
- 5:41SPEAKER_01: And the short answer is no, they aren't.
- 5:42SPEAKER_00: Oh, okay.
- 5:43SPEAKER_01: In this context, scientists often prefer to call the mesenchymal stromal cells because their main job isn't to act as building blocks to make new skin.
- 5:53SPEAKER_00: So what are they doing?
- 5:54SPEAKER_01: Instead of building tissue, they release chemical messages.
- 5:57SPEAKER_01: They send out signals to calm down that harmful inflammation and support the body's own tissue repair.
- 6:02SPEAKER_00: Oh wow.
- 6:02SPEAKER_00: So they're communicators.
- 6:04SPEAKER_01: Yes.
- 6:05SPEAKER_01: If we connect this to the bigger picture, it really differentiates MSCs from things like hematopoietic stem cells.
- 6:11SPEAKER_00: Aaron Powell, those are the ones used for blood and bone marrow care, right?
- 6:14SPEAKER_01: Exactly.
- 6:14SPEAKER_01: Which require very strict hospital settings because you're essentially rebuilding an immune system.
- 6:19SPEAKER_00: But MSCs are different.
- 6:21SPEAKER_01: Very different.
- 6:21SPEAKER_01: MSCs are unique because they act as immune modulators.
- 6:25SPEAKER_00: Aaron Ross Powell Immune Mulators.
- 6:27SPEAKER_00: Yeah.
- 6:27SPEAKER_00: Okay.
- 6:28SPEAKER_00: So if the overactive immune system is a panicked crowd, MSCs aren't the riot police forcefully arresting people, which is kind of what harsh drugs do.
- 6:37SPEAKER_00: Right.
- 6:38SPEAKER_00: They are more like the calm diplomats, the ones walking into the room with megaphones, telling everyone to stand down and just relax.
- 6:45SPEAKER_01: Aaron Powell That's a perfect analogy.
- 6:47SPEAKER_01: They are cellular diplomats.
- 6:49SPEAKER_00: Okay, so we understand the theory of these diplomats, but how does this actually play out in human trials?
- 6:55SPEAKER_01: The clinical literature is really robust here.
- 6:58SPEAKER_00: And we want to know what it looks like inside Cyrona cells' actual treatment rooms, too.
- 7:02SPEAKER_01: Aaron Powell Well, let's look at the research first.
- 7:04SPEAKER_01: The sources detail a case report from the Academy of Military Medical Sciences in Beijing.
- 7:09SPEAKER_00: Okay.
- 7:09SPEAKER_01: They used MSE transplantation for a psoriasis patient.
- 7:13SPEAKER_01: And there's an even bigger phase 12A trial from Central South University.
- 7:17SPEAKER_00: What did that trial show?
- 7:18SPEAKER_01: It showed definitive shifts in regulatory T cells and TH17 markers.
- 7:23SPEAKER_00: Which means the inflammation was actually calming down at the cellular level.
- 7:26SPEAKER_01: Exactly.
- 7:27SPEAKER_01: There's also a great case study by Wang and colleagues.
- 7:30SPEAKER_01: A young man with severe plaxoriasis showed massive improvement using donor gingival MSCs.
- 7:37SPEAKER_00: Gingival, like from the gums.
- 7:39SPEAKER_01: Yeah, administered via CV, and his improvement was striking.
- 7:42SPEAKER_00: Okay, here's where it gets really interesting.
- 7:45SPEAKER_00: But I have to ask a hard question.
- 7:47SPEAKER_00: We are throwing around words like improved and calmed quite a bit.
- 7:51SPEAKER_00: Are we talking about a cure here?
- 7:53SPEAKER_01: No.
- 7:54SPEAKER_01: Definitively no.
- 7:55SPEAKER_00: Okay, I think it's important to be clear about that.
- 7:57SPEAKER_01: It is crucial.
- 7:58SPEAKER_01: There is no guaranteed cure for psoriasis.
- 8:00SPEAKER_01: And Sirona is very upfront about this.
- 8:03SPEAKER_01: They position this as an adjunct therapy.
- 8:05SPEAKER_00: Meaning it's an add-on.
- 8:06SPEAKER_01: Right.
- 8:06SPEAKER_01: It's an add-on to standard dermatology, tracking your lifestyle, managing stress.
- 8:11SPEAKER_01: It's not a magic bullet that replaces everything else.
- 8:13SPEAKER_00: Aaron Powell So what does the actual patient experience look like at Cyrona if someone goes in for this?
- 8:18SPEAKER_01: It's very comprehensive.
- 8:20SPEAKER_01: It starts with a thorough medical evaluation.
- 8:23SPEAKER_01: They review your reports, your photos, your history.
- 8:26SPEAKER_00: Making sure you're actually a candidate.
- 8:27SPEAKER_01: Yes.
- 8:28SPEAKER_01: Then there's the lab prep.
- 8:30SPEAKER_01: Remember those strict batch testing protocols we talked about?
- 8:33SPEAKER_00: BSL2 standards, yeah.
- 8:34SPEAKER_01: Right.
- 8:35SPEAKER_01: They do all that testing before administration.
- 8:37SPEAKER_01: And the administration itself is actually a minimally invasive IV drip.
- 8:43SPEAKER_00: Oh, so no surgery.
- 8:45SPEAKER_01: No surgery at all.
- 8:46SPEAKER_01: You're just in a relaxing chair.
- 8:47SPEAKER_01: Yeah.
- 8:48SPEAKER_01: And then, of course, there's extensive follow-up to track the progress.
- 8:51SPEAKER_00: It sounds incredibly streamlined.
- 8:53SPEAKER_00: Oh, and I noticed that the sources also mention exosomes.
- 8:56SPEAKER_01: Ah, yes.
- 8:57SPEAKER_01: Exosomes are an added value service at Sorona.
- 9:00SPEAKER_00: What exactly are they?
- 9:01SPEAKER_00: Like how do they differ from the MSCs?
- 9:03SPEAKER_01: Think of them as tiny messenger packets that are actually released by the stem cells.
- 9:07SPEAKER_00: Okay, so the diplomats with megaphones, exosomes are like the pamphlets they hand out to the crowd?
- 9:13SPEAKER_01: Exactly.
- 9:14SPEAKER_01: They carry helpful signals that penetrate tissues deeply to further calm the inflammation.
- 9:19SPEAKER_00: Wow.
- 9:20SPEAKER_00: Okay, so we've covered a lot of ground today.
- 9:21SPEAKER_01: We really have.
- 9:22SPEAKER_00: To summarize this journey, we explored how Cyrona cell operates as the safe, science-led harbor in Malaysia.
- 9:30SPEAKER_01: Focusing on ethical practices from start to finish.
- 9:32SPEAKER_00: Right.
- 9:33SPEAKER_00: And they use MSCs and exosomes not as miraculous new skin builders, but as cellular signals, signals that calm the overactive immune response of psoriasis.
- 9:42SPEAKER_01: They're changing the communication of the body.
- 9:44SPEAKER_00: So what does this all mean?
- 9:46SPEAKER_00: Why does this matter to you, the listener?
- 9:48SPEAKER_01: It's a fundamental shift in perspective.
- 9:50SPEAKER_00: It really is.
- 9:51SPEAKER_00: Whether you suffer from an autoimmune issue or you know someone who does, or even if you're just fascinated by the frontier of medicine, the big takeaway is that the future of healing is about balance.
- 10:01SPEAKER_01: Balance and communication at the cellular level.
- 10:03SPEAKER_01: Yes.
- 10:04SPEAKER_00: Rather than just blunt force symptom management.
- 10:07SPEAKER_01: You know, this raises an important question.
- 10:09SPEAKER_01: If these tiny, ethically sourced cells can essentially act as software updates to reprogram our overzealous immune systems, how might this change our entire philosophical approach to chronic illness?
- 10:22SPEAKER_01: Are we moving away from fighting our bodies' diseases and finally learning how to just talk our bodies out of them?
- 10:28SPEAKER_00: Just talking our bodies out of them?
- 10:30SPEAKER_00: That is a wild thought to leave on.
- 10:32SPEAKER_00: Thank you so much for joining us on this deep dive, everyone.
- 10:35SPEAKER_01: It's been a pleasure.
- 10:36SPEAKER_00: Remember to stay curious, and we'll catch you on the next one.